VRAD's total revenue increased 8% to $30.8M for quarter ended March 31, 2010

NewsGuard 100/100 Score

MicroStockProfit.com announces an investment report featuring Virtual Radiologic Corp. (Nasdaq:VRAD). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

The full report is available at: www.microstockprofit.com/ads/VRAD

Virtual Radiologic Corp. (VRAD) is a radiology practice working in partnership with radiologists and hospitals to optimize radiology's role in the delivery of patient care.  Virtual Radiologic Professionals, LLC (VRP), is its affiliated physician-owned medical practice that contracts with independent contractor physicians for the provision of their services to fulfill customer contracts held by vRad or by the Professional Corporations, consisting of Virtual Radiologic Professionals of California, Virtual Radiologic Professionals of Illinois, Virtual Radiologic Professionals of Michigan, Virtual Radiologic Professionals of Minnesota, Virtual Radiologic Professionals of New York and Virtual Radiologic Professionals of Texas.  It provides radiologic interpretations for a range of digital diagnostic imaging modalities, including computed tomography (CT), X-ray or plain film, magnetic resonance imaging (MRI), ultrasound, nuclear medicine and positron emission tomography (PET). 

Message Board Search for VRAD: http://www.boardcentral.com/boards/VRAD

In the report, the analyst notes:

"Total revenue increased 8% to $30.8 million for the quarter ended March 31, 2010, compared to $28.6 million for the quarter ended March 31, 2009.  The increase in revenue over the first quarter of 2009 resulted primarily from a 15% increase in the number of hospitals and medical facilities served to 1,205 as of March 31, 2010, representing approximately 21% of all hospitals in the United States.  

"VRAD and Providence Equity Partners, a leading global private equity firm that manages more than $22 billion in equity capital, recently announced that they have entered into a definitive agreement under which Providence will acquire all of the outstanding common stock of VRAD for $17.25 per share in cash."

SOURCE MicroStockProfit.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Balanced diet linked to better brain health and cognition, large-scale study shows